These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1779258)

  • 1. Impact of rokitamycin, a new 16-membered macrolide, on serum theophylline.
    Cazzola M; Matera MG; Paternò E; Scaglione F; Santangelo G; Rossi F
    J Chemother; 1991 Aug; 3(4):240-4. PubMed ID: 1779258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of teicoplanin and aminophylline during cotreatment with both medicaments.
    Angrisani M; Cazzola M; Loffreda A; Losasso C; Lucarelli C; Rossi F
    Int J Clin Pharmacol Res; 1992; 12(4):165-71. PubMed ID: 1297639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of theophylline during co-treatment with ticarcillin plus clavulanic acid in patients suffering from acute exacerbation of chronic bronchitis.
    Matera MG; Cazzola M; Lampa E; Santangelo G; Paizis G; Vinciguerra A; Rossi F
    J Chemother; 1993 Aug; 5(4):233-6. PubMed ID: 8229151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The post-antibiotic effects of rokitamycin (a 16-membered ring macrolide) on susceptible and erythromycin-resistant strains of Streptococcus pyogenes.
    Braga PC; Culici M; Dal Sasso M
    Int J Antimicrob Agents; 2004 Sep; 24(3):254-60. PubMed ID: 15325429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
    Fontana G; Cresci F; Lo Sapio P; Panuccio P
    Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steady-state pharmacokinetics of theophylline in COPD patients treated with dirithromycin.
    Bachmann K; Jauregui L; Sides G; Sullivan TJ
    J Clin Pharmacol; 1993 Sep; 33(9):861-5. PubMed ID: 8227485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rokitamycin: bacterial resistance to a 16-membered ring macrolide differs from that to 14- and 15-membered ring macrolides.
    Braga PC
    J Chemother; 2002 Apr; 14(2):115-31. PubMed ID: 12017366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possibilities for optimizing therapy with theophylline preparations. I. On the pharmacokinetics of theophylline preparations].
    Wiesner B; Sehrt I; Iwainsky H
    Z Erkr Atmungsorgane; 1984; 162(1):3-10. PubMed ID: 6719957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
    Arbab OA; Wiggins J; Ayres JG; Stableforth DE
    Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial activity of rokitamycin compared with that of other macrolides.
    Yu KW; Briones F; Chin NX; Neu HC
    Diagn Microbiol Infect Dis; 1991; 14(4):331-5. PubMed ID: 1889182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the degree of susceptibility of Streptococcus pyogenes erythromycin-resistant strains to rokitamycin (a 16-membered macrolide) using the Epsilometer test.
    Crotti D; Rossetti R; Braga PC
    Drugs Exp Clin Res; 2004; 30(1):17-26. PubMed ID: 15134387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
    Steinijans VW; Zech K; Fischer R
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship among dosages of aminophylline, plasma levels of theophylline and variation of pulmonary arterial pressure].
    Liu S; Chen W; Luo Y; Yuan Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1992 Mar; 23(1):87-90. PubMed ID: 1398633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Macrolide-theophylline interaction. Experiences in pediatrics].
    Pavesio D; Mora P; Leone L; Moresco V; Girardo G
    Minerva Pediatr; 1989 Jun; 41(6):323-8. PubMed ID: 2601650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic disposition of theophylline in horses after intravenous administration.
    Kowalczyk DF; Beech J; Littlejohn D
    Am J Vet Res; 1984 Nov; 45(11):2272-5. PubMed ID: 6524719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in-vitro study on the metabolism of rokitamycin and possible interactions of the drug with rat liver microsomes.
    Zhao XJ; Ishizaki T
    J Pharm Pharmacol; 1999 Oct; 51(10):1167-74. PubMed ID: 10579688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rokitamycin in the treatment of female genital Chlamydia and Mycoplasma infections. Comparative study vs josamycin ].
    Colombo U; Pifarotti G; Amidani M; Viezzoli T; Pifarotti P
    Minerva Ginecol; 1998 Nov; 50(11):491-7. PubMed ID: 9882991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion from intravenous to oral dosing using sustained-release theophylline tablets.
    Stein GE; Haughey DB; Ross RJ; Vakoutis J
    Drug Intell Clin Pharm; 1982 Oct; 16(10):772-4. PubMed ID: 7140514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Miocamycin doesn't affect theophylline serum levels in COPD patients.
    Dal Negro R; Turco P; Pomari C; de Conti F
    Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):27-9. PubMed ID: 3261281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.